Screening and Natural History: Primary Lateral Sclerosis and Related Disorders

Key facts

Sponsor

National Institute of Neurological Disorders and Stroke (NINDS)

Principal Investigator

Mary Kay Floeter, M.D., MD

National Institute of Neurological Disorders and Stroke (NINDS)

Enrollment

189 enrolled

Eligibility

18 years · All sexes

Timeline

2001 – 2019

Study locations (1)

• National Institutes of Health Clinical Center, 9000 Rockville Pike, Bethesda, Maryland, United States

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Other trials for Primary lateral sclerosis

Additional recruiting or active studies for the same condition.

• ACTIVE NOT RECRUITINGPHASE1NCT02868567
  Use of Dalfampridine in Primary Lateral Sclerosis
  Hospital for Special Surgery, New York
• RECRUITINGNCT02567136
  Imaging Biomarkers in ALS
  University of Minnesota

See all trials for Primary lateral sclerosis →